title: Experimental hyperacute rejection in pancreas allotransplants.
abstract: A model of sensitization by intraperitoneal lymph node inoculation was developed to test the hypothesis that hyperacute rejection (HAR) could occur in sensitized recipients of vascularized pancreas allografts. Ten pairs of outbred mongrel dogs that were lymphocytotoxic cross-match assay negative were inoculated with homogenized lymph nodes on either three or four occasions at fortnightly intervals before renal transplantation. A renal allograft from the same donor was used to test the HAR response and to further enhance sensitization by rejection of a vascularized organ. Pancreas transplants were performed 2 weeks later, with biopsies of the graft and blood samples taken at 0, 10, 20, and 30 min and then at 30-min intervals until the grafts were no longer viable. All renal and pancreas grafts were rejected in a classical hyperacute pattern. Within 4 min of revascularization of the pancreas, central lobular hemorrhage and vascular congestion appeared, followed by general edema. Histology demonstrated parallel changes of edema, vascular congestion, necrosis, hemorrhage, and leukocytic infiltrate, which all preceded graft infarction. A sharp decline in both arterial and venous white blood cell count and platelets occurred within 10 min of revascularization with initial sequestration and subsequent release of platelets from the graft (P=0.02). In summary, HAR of the allografted pancreas can be observed by the surgeon within minutes of revascularization, with predictable macroscopic and microscopic changes. This study supports the use of routine lymphocytotoxic cross-match tests for all recipients of pancreas transplants and implies that particular care is warranted in regraft pancreas allograft recipients.
authors.affiliation: National Pancreas Transplant Unit, Westmead Hospital, Westmead NSW, Australia.
authors.forename: W J
authors.initials: WJ
authors.lastname: Hawthorne
authors.forename: A D
authors.initials: AD
authors.lastname: Griffin
authors.forename: H
authors.initials: H
authors.lastname: Lau
authors.forename: M
authors.initials: M
authors.lastname: Hibbins
authors.forename: J M
authors.initials: JM
authors.lastname: Grierson
authors.forename: H
authors.initials: H
authors.lastname: Ekberg
authors.forename: J R
authors.initials: JR
authors.lastname: Chapman
authors.forename: R D
authors.initials: RD
authors.lastname: Allen
mesh_terms: D000208:Acute Disease; D000818:Animals; D000961:Antilymphocyte Serum / Q000032:analysis; D001772:Blood Cell Count; D004285:Dogs; D005260:Female; D006084:Graft Rejection / Q000097:blood; D006650:Histocompatibility Testing; D008297:Male; D010179:Pancreas / Q000473:pathology; D016035:Pancreas Transplantation; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum